Form 4: Scholar Rock Director Kristina Burow Reports Equity Awards and Holdings

Sentiment:

Insider Transaction Report


Scholar Rock Holding Corp. Director Kristina Burow reported the acquisition of restricted stock units and stock options, alongside her direct and indirect beneficial ownership, as detailed in a recent SEC Form 4 filing.

Summary

  • Kristina Burow, a Director of Scholar Rock Holding Corp. (SRRK), filed a Form 4 statement of changes in beneficial ownership.
  • On May 22, 2025, Ms. Burow acquired 7,632 Restricted Stock Units (RSUs) at a price of $0.
  • Each RSU represents the contingent right to receive one share of the Issuer's common stock upon vesting, which occurs on the earlier of June 15, 2026, or the date of the Issuer's next Annual Meeting, subject to continued service.
  • She also acquired 9,206 stock options at a price of $0, with an exercise price of $30.46.
  • These options vest and become fully exercisable on the earlier of the first anniversary following the grant date or the date of the Issuer's next Annual Meeting, subject to continued service.
  • Following these transactions, Ms. Burow's direct beneficial ownership totals 26,471 shares of Common Stock, which includes 18,839 shares and the newly acquired 7,632 RSUs.
  • Additionally, she has indirect beneficial ownership of 2,345,711 shares of Common Stock held by ARCH Venture Fund VIII, L.P., though she disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein.

Sentiment

Score: 7

Explanation: The filing indicates a director's receipt of equity compensation, aligning their interests with shareholders, which is generally a positive signal for corporate governance and retention. It is a routine transaction and not indicative of significant operational or financial changes.

Positives

  • The acquisition of restricted stock units and stock options aligns the director's interests with those of shareholders, incentivizing long-term company performance.
  • The equity awards are part of standard compensation practices, indicating continued commitment and retention of key personnel.

Future Outlook

The document details the vesting schedules for the granted equity awards, indicating that the RSUs will vest on the earlier of June 15, 2026, or the next Annual Meeting, and options will vest on the earlier of the first anniversary of the grant or the next Annual Meeting, both subject to continued service.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction, specifically the grant of equity compensation to a director. Such grants are common practice across the biotechnology and pharmaceutical industries to align management and board interests with long-term shareholder value.

Stakeholder Impact

  • Shareholders: The grant of equity awards to a director aligns their financial interests with the long-term performance of the company, potentially benefiting shareholders through improved governance and strategic focus.

Next Steps

  • Vesting of 7,632 Restricted Stock Units on the earlier of June 15, 2026, or the date of the Issuer's next Annual Meeting, subject to continued service.
  • Vesting and exercisability of 9,206 Stock Options on the earlier of the first anniversary following the grant date or the date of the Issuer's next Annual Meeting, subject to continued service.

Key Dates

DateDescription
05/22/2025Date of earliest transaction, including the acquisition of 7,632 Restricted Stock Units and 9,206 Stock Options.
05/23/2025Date the Form 4 was signed by the Attorney-in-Fact for Kristina Burow.
06/15/2026Latest vesting date for the acquired Restricted Stock Units.
05/22/2035Expiration date for the acquired Stock Options.

Recommendation

hold

Keywords

Scholar Rock Holding Corp, SRRK, Form 4, SEC filing, insider transaction, director, equity awards, restricted stock units, stock options, beneficial ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.